SCHEMBL26946396

SCHEMBL26946396

O=C(CO)c1ccc(-c2ccc(F)cc2)c(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 4/20 0.46
▸ AKR1C2 P52895 4/20 0.46
▸ S1PR1 P21453 2/20 0.45
▸ SRD5A2 P31213 1/20 0.44
▸ ADH5 P11766 1/20 0.44
▸ PDE3B Q13370 3/20 0.42
▸ PDE3A Q14432 3/20 0.42
▸ PLOD2 O00469 1/20 0.41
▸ KIF11 P52732 1/20 0.40
▸ BCL2L1 Q07817 1/20 0.40
▸ BAD Q92934 1/20 0.40
▸ ROCK2 O75116 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ ADCY8 P40145 1/20 0.39
▸ ADCY1 Q08828 1/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ VNN1 O95497 1/20 0.38
▸ AKR1B10 O60218 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30991476 0.88 AKR1C3 (0.50) AKR1C3AKR1C2S1PR1SRD5A2ADH5
SCHEMBL30991468 0.86 AKR1C3 (0.48) AKR1C3AKR1C2S1PR1SRD5A2ADH5
SCHEMBL5430185 0.79 TAS1R3 (0.47) KIF11VNN1
SCHEMBL26919869 0.78 SRD5A2 (0.47) AKR1C3AKR1C2S1PR1SRD5A2ADH5
SCHEMBL26920142 0.78 SRD5A2 (0.47) AKR1C3AKR1C2S1PR1SRD5A2ADH5
SCHEMBL26919872 0.78 SRD5A2 (0.47) AKR1C3AKR1C2S1PR1SRD5A2ADH5
SCHEMBL30991461 0.76 SRD5A2 (0.46) AKR1C3AKR1C2S1PR1SRD5A2ADH5
SCHEMBL23302210 0.76 ADH5 (0.63) AKR1C3AKR1C2SRD5A2ADH5BCL2L1
SCHEMBL26946408 0.75 S1PR1 (0.46) AKR1C3AKR1C2S1PR1SRD5A2ADH5
SCHEMBL28098468 0.75 MAPT (0.54) AKR1C3AKR1C2S1PR1SRD5A2ADH5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023237651-A1 METHOD FOR THE PREPARATION OF A 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONE BAYER AKTIENGESELLSCHAFT (DE) 2023-12-14 — — WO disclosed
EP-4289828-A1 METHOD FOR THE PREPARATION OF A 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONE Bayer Aktiengesellschaft (DE) 2023-12-13 — — EP disclosed
Send feedback